Quick Answer
Sana Biotechnology, Inc. reported Operating Income of -$250.32 million for fiscal year 2025.
Sana Biotechnology, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$250.32M | +8.2% |
| 2024 | -$272.72M | +7.0% |
| 2023 | -$293.14M | -7.5% |
| 2022 | -$272.56M | +23.6% |
| 2021 | -$356.91M | -24.7% |
| 2020 | -$286.15M | -102.7% |
| 2019 | -$141.15M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$43.52M | +29.5% | +54.2% |
| June 30, 2025 | -$94.97M | -92.4% | -87.6% |
| March 31, 2025 | -$50.63M | +54.3% | +18.0% |
| September 30, 2024 | -$61.76M | -2731.8% | -25.1% |
| June 30, 2024 | -$49.37M | +57.5% | +55.4% |
| March 31, 2024 | -$110.72M | -31.7% | -4976.8% |
| September 30, 2023 | -$2.18M | +97.5% | +98.1% |
| June 30, 2023 | -$116.29M | -59.5% | -38.4% |
- Sana Biotechnology, Inc. showed an increase of +8.2% in Operating Income compared to the prior fiscal year.
- Over the 2019–2025 period, Sana Biotechnology, Inc.’s operating income has declined by 77.3% (from -$141.15 million to -$250.32 million).
- The most recent figure is from Sana Biotechnology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: